Right now, a 50-basis-point Fed raise upon the cessation of the asset purchase program winding down currently is expected at the Fed’s March 15-16 meeting.
Author archives: Mark Vickery
Inflation Back on Front Burner: CPI +0.6% Not Cool (revised)
We had been looking for these numbers to moderate over time, but so far they’ve not done so.
Markets Stampede into the Green; CVS, GSK Beat, YUM Mixed
Seeing our economy gaining in growth is a good reason for investors to become a little less risk-averse.
Quarterly Beats for Tyson (TSN), Onsemi (ON) and Hasbro (HAS)
Later this week, we’ll see new earnings results from The Walt Disney Co. (DIS), Uber (UBER), Coca Cola (KO) and Peloton (PTON).
Huge Jobs Surprise: 467K, Unemployment Rate 4.0%
A total of 467K new jobs were created last month, more than triple the 150K expected, while the Unemployment Rate ticked up to 4.0% from 3.9% previously.
Top Research Reports for Chevron, HSBC & Anthem
Today’s Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), HSBC Holdings plc (HSBC), and Anthem, Inc. (ANTM).
Big Data for Q4, Econ to Start a New Month
We’ve got a big day ahead with both economic prints and Q4 earnings reports.
Good Riddance to a Rough Trading Month
It would be easy to forget we started out its first few trading days notching new all-time highs on both the Dow and the S&P 500.
Q4 GDP at +6.9%; Jobless Claims, Durable Goods Lower
+6.9% on the headline is 140 basis points higher than expected, and 3x times higher than Q3’s +2.3%.
Top Analyst Reports for AbbVie, Edwards Lifesciences & Johnson Controls
Today’s Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Edwards Lifesciences Corporation (EW), and Johnson Controls International plc (JCI).